Related Experiment Videos
Methanopyrus kandleri glutamyl-tRNA reductase
J Moser1, S Lorenz, C Hubschwerlen
1Institut für Organische Chemie und Biochemie, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg im Breisgau, Germany.
The Journal of Biological Chemistry
|October 16, 1999
Summary
Glutamyl-tRNA reductase (GluTR) from Methanopyrus kandleri was cloned and characterized. This enzyme is crucial for tetrapyrrole formation in archaea, with specific catalytic and substrate binding mechanisms identified.
Area of Science:
- Biochemistry
- Enzymology
- Archaea Biology
Background:
- Tetrapyrrole compounds are essential biological molecules.
- Archaea utilize unique biochemical pathways for their synthesis.
- Glutamyl-tRNA reductase (GluTR) initiates tetrapyrrole formation via glutamate activation.
Purpose of the Study:
- To clone and characterize the gene encoding GluTR from the thermophilic archaeon Methanopyrus kandleri.
- To elucidate the catalytic mechanism and substrate requirements of M. kandleri GluTR.
- To identify key amino acid residues involved in GluTR catalysis.
Main Methods:
- Gene cloning and overexpression in Escherichia coli.
- Purification and biochemical characterization of recombinant GluTR.
- Enzyme kinetics assays, including substrate analogue and inhibitor studies.
- Site-directed mutagenesis and chemical modification of the enzyme.
Main Results:
- Recombinant M. kandleri GluTR is a tetrameric enzyme with optimal activity at 90°C and pH 8.1.
- The enzyme requires NADPH and is inhibited by heavy metals and heme.
- Glutamycin inhibition highlights the necessity of an intact glutamate-tRNA bond for substrate recognition.
- Cysteine-48 and Histidine-84 residues are critical for catalysis, forming a thioester intermediate.
Conclusions:
- M. kandleri GluTR catalyzes the initial step of tetrapyrrole formation through a novel mechanism involving a thioester intermediate.
- The enzyme's high thermostability and unique catalytic features provide insights into archaeal biochemistry.
- Understanding GluTR's mechanism can inform the development of novel inhibitors and therapeutic strategies.